EE200300222A - 4-(17a-asendatud-3-oksoöstra-4,9-dieen-11ß-üül)-bensaldehüüd-(1E või 1Z)-oksiimide valmistamismeetod - Google Patents

4-(17a-asendatud-3-oksoöstra-4,9-dieen-11ß-üül)-bensaldehüüd-(1E või 1Z)-oksiimide valmistamismeetod

Info

Publication number
EE200300222A
EE200300222A EEP200300222A EEP200300222A EE200300222A EE 200300222 A EE200300222 A EE 200300222A EE P200300222 A EEP200300222 A EE P200300222A EE P200300222 A EEP200300222 A EE P200300222A EE 200300222 A EE200300222 A EE 200300222A
Authority
EE
Estonia
Prior art keywords
sub
oximes
substituted
estra
benzaldehyde
Prior art date
Application number
EEP200300222A
Other languages
English (en)
Inventor
Schubert Gerd
Ring Sven
Erhart Bernd
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of EE200300222A publication Critical patent/EE200300222A/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0085—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Epoxy Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Studio Devices (AREA)
EEP200300222A 2000-11-10 2001-11-09 4-(17a-asendatud-3-oksoöstra-4,9-dieen-11ß-üül)-bensaldehüüd-(1E või 1Z)-oksiimide valmistamismeetod EE200300222A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10056676A DE10056676A1 (de) 2000-11-10 2000-11-10 Verfahren zur Herstellung von 4-/17alpha-substituierten-3-oxoestra-4,9-dien-11beta-yl)benzaldehyd-(1E oder 1Z)-oximen
PCT/DE2001/004218 WO2002038582A2 (de) 2000-11-10 2001-11-09 Verfahren zur herstellung von 4-(17alpha-(substituierten-methyl)-3-oxoestra-4,9 dien-11-yl)benzaldehyd-(1e oder 1z)-oximen

Publications (1)

Publication Number Publication Date
EE200300222A true EE200300222A (et) 2003-08-15

Family

ID=7663441

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300222A EE200300222A (et) 2000-11-10 2001-11-09 4-(17a-asendatud-3-oksoöstra-4,9-dieen-11ß-üül)-bensaldehüüd-(1E või 1Z)-oksiimide valmistamismeetod

Country Status (26)

Country Link
US (1) US7214808B2 (et)
EP (1) EP1339734B1 (et)
JP (1) JP4263478B2 (et)
KR (1) KR100836323B1 (et)
CN (1) CN100368427C (et)
AT (1) ATE337328T1 (et)
AU (2) AU1691102A (et)
BG (1) BG107886A (et)
BR (1) BR0115249A (et)
CA (1) CA2427632C (et)
CZ (1) CZ301425B6 (et)
DE (2) DE10056676A1 (et)
EA (1) EA005530B1 (et)
EE (1) EE200300222A (et)
HK (1) HK1063187A1 (et)
HR (1) HRP20030458A2 (et)
HU (1) HUP0301765A2 (et)
IL (2) IL155680A0 (et)
MX (1) MXPA03004109A (et)
NO (1) NO20032080L (et)
NZ (1) NZ525962A (et)
PL (1) PL205091B1 (et)
SK (1) SK286601B6 (et)
WO (1) WO2002038582A2 (et)
YU (1) YU34303A (et)
ZA (1) ZA200304480B (et)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006018888A1 (de) * 2006-04-18 2007-10-25 Bayer Schering Pharma Ag Verfahren zur Herstellung von 4-[17beta-Methoxy-17alpha-methoxymethyl-3-oxoestra-4,9-dien-11beta-yl]benzaldehyd-(E)-oxims (Asoprisnil)
JP4843372B2 (ja) * 2006-05-09 2011-12-21 株式会社リコー 画像処理装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4332283A1 (de) * 1993-09-20 1995-04-13 Jenapharm Gmbh Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4332284C2 (de) * 1993-09-20 1997-05-28 Jenapharm Gmbh 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5576310A (en) * 1994-09-20 1996-11-19 Jenapharm Gmbh 11-benzaldoxime-17β-methoxy-17α-methoxymethyl-estrasdiene derivatives, methods for their production and pharmaceuticals containing such compounds

Also Published As

Publication number Publication date
EA005530B1 (ru) 2005-04-28
WO2002038582A2 (de) 2002-05-16
ATE337328T1 (de) 2006-09-15
ZA200304480B (en) 2004-08-24
WO2002038582A3 (de) 2002-09-12
CZ20031282A3 (cs) 2003-08-13
BR0115249A (pt) 2003-08-12
EA200300506A1 (ru) 2003-12-25
JP2004513179A (ja) 2004-04-30
EP1339734B1 (de) 2006-08-23
AU2002216911B2 (en) 2007-06-14
US7214808B2 (en) 2007-05-08
NO20032080D0 (no) 2003-05-09
CN100368427C (zh) 2008-02-13
AU2002216911C1 (en) 2002-05-21
PL361399A1 (en) 2004-10-04
PL205091B1 (pl) 2010-03-31
EP1339734A2 (de) 2003-09-03
SK286601B6 (sk) 2009-02-05
BG107886A (bg) 2004-02-27
HRP20030458A2 (en) 2005-04-30
IL155680A0 (en) 2003-11-23
CZ301425B6 (cs) 2010-02-24
MXPA03004109A (es) 2004-07-08
YU34303A (sh) 2006-08-17
US20040053905A1 (en) 2004-03-18
KR20030081330A (ko) 2003-10-17
NZ525962A (en) 2005-02-25
DE50110829D1 (de) 2006-10-05
CA2427632A1 (en) 2003-05-01
HUP0301765A2 (hu) 2003-09-29
NO20032080L (no) 2003-05-09
IL155680A (en) 2009-06-15
HK1063187A1 (en) 2004-12-17
CA2427632C (en) 2010-01-26
SK5512003A3 (en) 2003-10-07
DE10056676A1 (de) 2002-05-16
AU1691102A (en) 2002-05-21
JP4263478B2 (ja) 2009-05-13
CN1474829A (zh) 2004-02-11
KR100836323B1 (ko) 2008-06-09

Similar Documents

Publication Publication Date Title
EA200000358A1 (ru) Способ получения диарилпиридинов, полезных в качестве ингибиторов cox-2
NO329883B1 (no) Fremgangsmate for fremstilling av prostaglandiner og analoger derav og av mellomforbindelser, og forbindelser fremstilt derved
KR860007209A (ko) 트리치환 안식향산 중간체의 제법
ATE332304T1 (de) Cefdinir salze als zwischenprodukte
DK1127886T3 (da) Syntese af 3,6-dialkyl-5,6-dihydro-4-hydroxy-2H-pyran-2-on
NO20040388L (no) Fremgangsmåte for fremstilling av beraprost og salter derav, samt forbindelser som er mellomprodukter i fremgangsmåten
ATE428693T1 (de) Prostaglandinsynthese
EE200300222A (et) 4-(17a-asendatud-3-oksoöstra-4,9-dieen-11ß-üül)-bensaldehüüd-(1E või 1Z)-oksiimide valmistamismeetod
DK0801054T3 (da) Fremgangsmåde til fremstilling af 2-(2-hydroxymethylphenyl)acetamidderivater og mellemprodukter til fremstilling deraf
DK0781764T3 (da) Fremgangsmåde til fremstilling af alkoxyiminoacetamid-derivater
WO2002024690A3 (en) Efficient process for the preparation of a factor xa inhibitor
NO20053712L (no) Fremgangsmate for fremstilling av substituerte imidazolderivater og mellomprodukter anvendt i fremgangsmaten
DK1347960T3 (da) Fremgangsmåde til fremstilling af (+/-) trans-4-p-fluorphenyl-3-hydromethyl-1-methylpiperidin
WO2002038581A3 (de) Verfahren zur herstellung von 4-(17alpha-substituierten-methyl) 3-oxoestra-4,9-dien-11beta-yl)benzaldehyd-(1e oder 1z)-oximen
EE05136B1 (et) Asendatud imidasopridiinhendite valmistamise meetod
PT1250335E (pt) Processo e intermediarios para a preparacao de imidazopiridinas
DK1219625T3 (da) Hidtil ukendte substituerede 2-(6-benzyl-5-oxo-3-phenyl-(S3,7S,7AR)-perhydroimidazol-(1,5-C)(1,3) thiazol-7YL)forbindelser
DK0703237T3 (da) Fremgangsmåde til fremstilling af thio-phospholipider af ether-typen
NO20030605L (no) Fremgangsmåte for fremstilling av imidazo-(1,2-C)(2,3)- benzodiazepiner, samt mellomprodukter ved fremstillingen derav
DK61191A (da) Fremgangsmaade til fremstilling af 1alfa-silyloxy-4alfa-hydroxy-3beta-(3alfa-hydroxy-4-phenoxy-buten-1-yl)-cyclopent-2alfa-yl-alkynderivater
IT1318651B1 (it) Sintesi di (+-)1,3-diossolani e loro risoluzione ottica.
EA200100064A1 (ru) Способ получения замещенных пиридинкарбоновых кислот
DK0675880T3 (da) Quinolondisulfider som mellemprodukter
NO20002497D0 (no) Prosess for eterspaltning
WO2002069909A3 (en) Synthesis of ketosulfone esters